Acurx Pharmaceuticals earnings were -$16.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ACXP earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.8M, down 31.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ACXP reported annual earnings of -$14.6M, with 20.5% growth. The next ACXP earnings date is Mar 17, 2025.
Acurx Pharmaceuticals Earnings Reports & History FAQ
What were Acurx Pharmaceuticals's earnings last quarter?
On ACXP's earnings call on Invalid Date, Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 2024 earnings per share (EPS) of -$0.17, up 29.17% year over year. Total ACXP earnings for the quarter were -$2.82 million. In the same quarter last year, Acurx Pharmaceuticals's earnings per share (EPS) was -$0.24.
The next ACXP earnings call is Invalid Date. Add ACXP to your watchlist to be reminded of Acurx Pharmaceuticals's next earnings date.
What was ACXP's earnings growth in the past year?
As of Acurx Pharmaceuticals's earnings date in Invalid Date, Acurx Pharmaceuticals's earnings has grown year over year. ACXP earnings in the past year totalled -$16.44 million.
Is Acurx Pharmaceuticals profitable or losing money?
As of the last Acurx Pharmaceuticals earnings report, Acurx Pharmaceuticals is currently losing money. Acurx Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$16.44 million, a 29.18% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.